These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30828008)

  • 1. Prognostic Value of Plasma Big Endothelin-1 Level among Patients with Three-Vessel Disease: A Cohort Study.
    Zhang C; Tian J; Jiang L; Xu L; Liu J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu B; Zhao W; Hui R; Gao R; Yuan J; Song L
    J Atheroscler Thromb; 2019 Nov; 26(11):959-969. PubMed ID: 30828008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma big endothelin-1 level and the severity of new-onset stable coronary artery disease.
    Chen J; Chen MH; Guo YL; Zhu CG; Xu RX; Dong Q; Li JJ
    J Atheroscler Thromb; 2015; 22(2):126-35. PubMed ID: 25195814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease.
    Zhao X; Jiang L; Xu L; Tian J; Xu Y; Zhao Y; Feng X; Wu Y; Zhang Y; Wang D; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Song L; Yuan J
    Eur J Prev Cardiol; 2019 May; 26(8):872-882. PubMed ID: 30861699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between plasma big endothelin-1 levels at admission and long-term outcomes in patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Atherosclerosis; 2018 May; 272():1-7. PubMed ID: 29529394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the stress hyperglycemia ratio on long-term mortality in patients with triple-vessel disease and acute coronary syndrome.
    Zhang Y; Guo L; Zhu H; Jiang L; Xu L; Wang D; Zhang Y; Zhao X; Sun K; Zhang C; Zhao W; Hui R; Gao R; Wang J; Yuan J; Xia Y; Song L
    Cardiovasc Diabetol; 2024 Apr; 23(1):143. PubMed ID: 38664806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of high sensitivity C-reactive protein in three-vessel disease patients with and without type 2 diabetes.
    Guo L; Lv H; Wang J; Zhang B; Zhu Y; Zhang X; Zhu H; Zhou X; Xia Y
    Cardiovasc Diabetol; 2023 Apr; 22(1):91. PubMed ID: 37081535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of plasma big endothelin-1 in patients with light chain cardiac amyloidosis.
    Chen Z; Shi A; Wang Z; Chen Y; Lin Y; Su M; Dong H; Laptseva N; Hu Y; Flammer AJ; Duru F; Jin W; Chen L
    Heart; 2024 Aug; 110(18):1124-1132. PubMed ID: 39084705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma big endothelin-1 levels at admission and future cardiovascular outcomes: A cohort study in patients with stable coronary artery disease.
    Zhou BY; Guo YL; Wu NQ; Zhu CG; Gao Y; Qing P; Li XL; Wang Y; Dong Q; Liu G; Xu RX; Cui CJ; Sun J; Li JJ
    Int J Cardiol; 2017 Mar; 230():76-79. PubMed ID: 28038820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Values of Serum Chloride and Sodium Levels in Patients with Three-vessel Disease.
    Zhang C; Wang D; Hou BJ; Jiang L; Xu LJ; Tian J; Zhao YY; Zhao XY; Feng XX; Zhang Y; Sun K; Xu B; Zhao W; Hui RT; Gao RL; Lou HL; Yuan JQ; Song L
    Biomed Environ Sci; 2019 Apr; 32(4):250-259. PubMed ID: 31217061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Big endothelin-1 level is a useful marker for predicting the presence of isolated coronary artery ectasia.
    Wang Y; Zhang Y; Zhu CG; Guo YL; Huang QJ; Wu NQ; Gao Y; Qing P; Liu G; Dong Q; Li JJ
    Biomarkers; 2017; 22(3-4):331-336. PubMed ID: 27885846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy.
    Wang Y; Tang Y; Zou Y; Wang D; Zhu L; Tian T; Wang J; Bao J; Hui R; Kang L; Song L; Wang J
    Int J Cardiol; 2017 Sep; 243():283-289. PubMed ID: 28587741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
    Fan P; Zhang Y; Lu YT; Yang KQ; Lu PP; Zhang QY; Luo F; Lin YH; Zhou XL; Tian T
    Heart; 2021 May; 107(10):836-841. PubMed ID: 33055147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study.
    Li X; Chen C; Gan F; Wang Y; Ding L; Hua W
    BMC Cardiovasc Disord; 2014 May; 14():67. PubMed ID: 24885051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved 5-year prediction of all-cause mortality by coronary CT angiography applying the CONFIRM score.
    Deseive S; Shaw LJ; Min JK; Achenbach S; Andreini D; Al-Mallah MH; Berman DS; Budoff MJ; Callister TQ; Cademartiri F; Chang HJ; Chinnaiyan K; Chow BJ; Cury RC; DeLago A; Dunning AM; Feuchtner G; Kaufmann PA; Kim YJ; Leipsic J; Marques H; Maffei E; Pontone G; Raff G; Rubinshtein R; Villines TC; Hausleiter J; Hadamitzky M
    Eur Heart J Cardiovasc Imaging; 2017 Mar; 18(3):286-293. PubMed ID: 28363203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of baseline big endothelin-1 level with long-term prognosis among cardiac resynchronization therapy recipients.
    Yang S; Liu Z; Liu S; Ding L; Chen K; Hua W; Zhang S
    Clin Biochem; 2018 Sep; 59():25-30. PubMed ID: 29913121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study.
    Qiao Z; Bian X; Song C; Zhang R; Yuan S; Lin Z; Zhu C; Liu Q; Ma W; Dou K
    Cardiovasc Diabetol; 2024 Jun; 23(1):190. PubMed ID: 38824608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Value of Big Endothelin-1 in the Assessment of the Severity of Coronary Artery Calcification.
    Wang F; Li T; Cong X; Hou Z; Lu B; Zhou Z; Chen X
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1042-1049. PubMed ID: 29562761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease.
    Li X; Wang Z; Zhu Y; Lv H; Zhou X; Zhu H; Liu J; Guo L
    J Inflamm Res; 2023; 16():5767-5777. PubMed ID: 38059151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery Disease.
    Xu N; Jiang L; Xu L; Tian J; Zhang C; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Song L; Yuan J
    Am J Cardiol; 2020 Feb; 125(4):528-533. PubMed ID: 31864520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.